Partial Agonistic Effect of Cetuximab on Epidermal Growth Factor Receptor and SRC Kinase Activation in Triple‑negative Breast Cancer Cell Lines

International Journal of Oncology - Greece
doi 10.3892/ijo.2019.4697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

Bulletin of Siberian Medicine
Molecular Medicine
2020English

Role of Epidermal Growth Factor Receptor in Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Estrogen Receptor Β1 Activation Accelerates Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

Down-Regulation of Cathepsin S and Matrix Metalloproteinase-9 via Src, a Non-Receptor Tyrosine Kinase, Suppresses Triple-Negative Breast Cancer Growth and Metastasis

Experimental & Molecular Medicine
2018English

Midostaurin Preferentially Attenuates Proliferation of Triple-Negative Breast Cancer Cell Lines Through Inhibition of Aurora Kinase Family

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2015English

Epidermal Growth Factor Stimulates Rac Activation Through SRC and Phosphatidylinositol 3-Kinase to Promote Colonic Epithelial Cell Migration

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2008English

Cisplatin in Combination With Zoledronic Acid: A Synergistic Effect in Triple-Negative Breast Cancer Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2013English

Cetuximab-Conjugates Nanoparticles for the Treatment of Triple Negative Breast Cancer

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy